Abstract Details

Title Case Report: Expanded Access Treatment of an Infantile Neuroaxonal Dystrophy Patient with a Novel Stabilized Polyunsaturated Fatty Acid Drug

Topic Child Neurology and Developmental Neurology

Presentation(s) P3 - (-)

Poster/Presentation
Number 327

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
PRESENTER	No disclosure on file
Janannaz Dastgir, DO (Atlantic health)	Dr. Dastgir has received personal compensation for serving as an employee of Regenxbio. Dr. Dastgir has a non-compensated relationship as a Scientific Advisory Board with Team Titin that is relevant to AAN interests or activities. Dr. Dastgir has a non-compensated relationship as a Scientific Advisory Board with Hannah's Hope Fund / Gengan Therapeutics that is relevant to AAN interests or activities.
Robert J. Molinari, PhD (Medstars, Inc.)	No disclosure on file
Frederic Heerinckx, PharmD (Retrotope, Inc.)	No disclosure on file

��ɫ��